Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001682852-19-000013
Filing Date
2019-04-25
Accepted
2019-04-25 17:15:49
Documents
6
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A moderna10-ka12312018.htm 10-K/A 628975
2 EXHIBIT 10.24 exhibit102412312018ka.htm EX-10.24 17059
3 EXHIBIT 31.3 exhibit31312312018ka.htm EX-31.3 7296
4 EXHIBIT 31.4 exhibit31412312018ka.htm EX-31.4 6339
5 exhibit102412312018ka_image1.jpg GRAPHIC 19292
6 modernalogo.jpg GRAPHIC 63925
  Complete submission text file 0001682852-19-000013.txt   775298
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38753 | Film No.: 19768384
SIC: 2836 Biological Products, (No Diagnostic Substances)